Angioslide is a medical device company that develops Embolic Capture Angioplasty device.
Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 1, 2015 | Series E | $3M | 2 | — | — | Detail |
Jan 3, 2013 | Series D | $6.30M | 2 | Triventures | — | Detail |
Aug 1, 2009 | Series C | $8.25M | 1 | — | — | Detail |
May 1, 2008 | Series B | $8.60M | 1 | — | — | Detail |
Dec 1, 2006 | Series A | $4M | 1 | Viola Partners | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Viola Partners | — | Series E |
Triventures | — | Series E |